|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02500 VENUS MEDTECH-B
Nominal 
1.225 +0.055 (+4.701%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 135,498 | -27.594% | 187,137 | 230,720 | 255,610 | 209,965 |
| Cost of Sales | (41,977) | -14.592% | (49,149) | (48,960) | (54,361) | (45,790) |
| Gross Profit | 93,521 | -32.225% | 137,988 | 181,760 | 201,249 | 164,175 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (5,014) | -- | 1,238 | 764 | (9,656) | (3,595) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (2,607) | 15.099% | (2,265) | (641) | (6,964) | (14,593) | |
| Profit / (Loss) before Taxation | (194,644) | 40.472% | (138,564) | (213,581) | (370,339) | (246,406) | |
| Taxation | 3,336 | -12.025% | 3,792 | 4,756 | 4,124 | 6,738 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 2,338 | 16,027 | 39,735 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (191,308) | 41.949% | (134,772) | (206,487) | (350,188) | (199,933) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 9,027 | 25.864% | 7,172 | 9,805 | 31,185 | 18,400 |
| Depreciation & Amortisation | 44,658 | -9.541% | 49,368 | 58,490 | 56,056 | -- |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -44.000 | 41.935% | -31.000 | -47.000 | -80.000 | -46.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.460 | -- | 4.685 | 6.180 | 7.511 | 10.023 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -191,308 |
| %Change | 41.949% |
| EPS / (LPS) | RMB -0.440 |
| NBV Per Share (¥) | RMB 3.460 |